TNFRSF9 and neoplasm: Collectively, these data suggest that MCLA-145 could intensify antigen-specific T cell responses in the tumor micro-environment by simultaneously blocking the inhibition of TCR signaling by PD-1 in addition to providing costimulation through CD137 signaling.